Search

Author/Creator Varadhan, Balaji

1. Comparison between 1st generation EGFR tyrosine kinase inhibitor (gefitinib) versus 2nd generation (afatinib) in EGFR-mutated non-small cell lung cancers (NSCLC) – real world experience. (June 2021)

Authors:
Dulloo, Sean; Almusarhed, Manar; Chen, Ryan; Akala, Oyeyemi; Varadhan, Balaji; Chauhan, Meera; Ahmed, Samreen
Journal:
Lung cancer
Issue:
Volume 156(2021)Supplement 1
Page Start:
S42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search